Valtropins effekt og sikkerhed er vurderet i et randomiseret, dobbeltblindt, parallelt, kontrolleret fase III- forsøg hos børn med væksthormonmangel.
The efficacy and safety of Valtropin has been assessed in a randomised, double-blind, parallel, controlled Phase III study in children with growth hormone deficiency.